Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Pilot Study of Atazanavir/Ritonavir/Efavirenz as a Nucleoside Sparing Regimen

This study has been completed.
Information provided by:
Bristol-Myers Squibb Identifier:
First received: August 25, 2005
Last updated: April 7, 2011
Last verified: July 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: October 2005
  Primary Completion Date: October 2005 (Final data collection date for primary outcome measure)